MDL 2700 — Genentech, Inc., Herceptin (Trastuzumab) Marketing and Sales Practices Litigation

Pending on the 2026-08-03 JPML roster.

Pending actions over time

Civil actions pending in this MDL, from JPML's monthly Actions-Pending reports.

Roster timeline

Each cell is one monthly JPML report (2014-02-19 → 2026-08-03); filled cells are months this MDL was on the pending roster.

Related Other Litigation

• MDL 2804 — National Prescription Opiate Litigation — 2,915 pending
• MDL 2492 — National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation — 558 pending
• MDL 1570 — Terrorist Attacks on September 11, 2001 — 372 pending
• MDL 2323 — National Football League Players' Concussion Injury Litigation — 329 pending
• MDL 2996 — McKinsey & Company, Inc., National Prescription Opiate Consultant Litigation — 235 pending
• MDL 3121 — MultiPlan Health Insurance Provider Litigation — 150 pending

All other litigation MDLs →

Sources

• JPML Pending MDLs (official)
• Roster report containing this row

Roster presence is our derivation from JPML's monthly PDFs; confirm current status with the court before relying on it.